Shares edged up modestly by 1.8% following Q2 results as investors took note of regulatory progress and commercial developments, though the market reaction signals no significant positive surprise or setback.

• Submitted a formal construction permit application (CPA) to the U.S. NRC for the KRONOS MMR full-scale prototype, marking an important regulatory milestone.
• Completed a feasibility study for supplying up to 1 gigawatt of power to a major AI data center and manufacturing campus in Texas, progressing commercial pipeline.
• Advancing M&A and strategic partnership discussions aimed at vertical integration across the nuclear fuel supply chain.
• Highlighted continued support from evolving NRC licensing frameworks (Part 53 and Part 57), which could streamline deployment timelines.
• No explicit margins, guidance revisions, or key metric slowdowns mentioned that would materially sway near-term investor sentiment.